Advertisement

Benzodiazepine and Non-Benzodiazepine Anxiolitics

  • Harold Goldberg

Abstract

Everyone experiences anxiety at some time in life. In fact, a mild degree of anxiety is frequently constructive since it motivates and often increases alertness. However, more severe anxiety may be counterproductive, preoccupying the individual with feelings of distress and frequently producing somatic symptoms. When anxiety reaches this proportion, it can be classified as an anxiety disorder.

Keywords

Anxiety Disorder Generalize Anxiety Disorder Somatic Symptom Panic Attack Imipramine Hydrochloride 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Vistaril In the Treatment of Neuroses, Psychosomatics, Vol, XIV, No.l. Presented at the 19th Annual Meeting of Academy of Psychosomatic Medicine, San Diego, CA (1972)Google Scholar
  2. 2.
    R.J. Greenblatt and R.I Shadet., Pharmacotherapy of Anxiety with Benzodiazepines and B-adrenergic Blockers, in Psychopharmacology: A Generation of Progress, M.Av Lipton, A. DiMascio, and K. Killam, eds., Raven Press, N.Y. (1974)Google Scholar
  3. 3.
    F. Donald Klein, C.H. Zitrin, and M. Woerner, Antidepressants, Anxiety, Panic and Phobia, in: Psychopharmacology, A Generation of Progress, M.A. Lipton, A DiMascio, and K.F. Killam, eds., Raven Press, New York (1978)Google Scholar
  4. 4.
    D.U. Sheehan, Panic Attacks and Phobias, New England Journal of Medicine, (1982)Google Scholar
  5. 5.
    Y.H. Wu, J.W. Rayburn, and L.E. Allen, U.S. Patent 3,717,634 (1973)Google Scholar
  6. 6.
    G.P. Casten, G.R. McKinney, and R.E. Newton, U.S. Patent 4,182,763, (1980)Google Scholar
  7. 7.
    Y.H. Wu, J.W. Rayburn and L.E. Allen, Psychosedative Agents: II. 5-(4-substituted 1-piperazinylaklyl-8-azaspiro (4.5) decane-7, 9-diones. J.Med. Chem. 15:477, (1972)CrossRefGoogle Scholar
  8. 8.
    L.A. Riblet, D.P. Taylor, M.S. Eison, Buspirone: Pharmacology and Neurochemistry, J.Clin. Psychiatry, 43:12, (1982Google Scholar
  9. 9.
    H. Moskowitz, A. Smiley, The Effects of Chronically Administered Buspirone and Diazepam on Driving-related Skills Performance. Ibid.Google Scholar
  10. 10.
    J.O. Cole and M.H. Orzack, Assessment of the Abuse Liability of Buspirone in Recreational Sedative Users, Ibid.Google Scholar
  11. 11.
    K. Rickeis, K. Weisman and D.O. Norstrad, Buspirone and Diaze pam in Anxiety: A Controlled Study, Ibid.Google Scholar
  12. 12.
    H. Goldberg, R.J. Finnerty, Comparative Efficacy of Buspirone and Diazepam in the Treatment of Anxiety. Am.J. Psychiatry, 136:1184, (1979)Google Scholar
  13. 13.
    H. Goldberg, R. Finnerty, Comparison of Buspirone in Two Sep. Studies. J.Clin.Psychiatry (1982)Google Scholar
  14. 14.
    D. Wheatley, Buspirone, Multicenter Efficacy Study, Ibid.Google Scholar
  15. 15.
    R.W. Newton, G.P. Casion, D.R. Alms, The Side Effect Profile of Buspirone in Comparison to Active Controls and Placebo, Ibid.Google Scholar
  16. 16.
    J.P. Feighner, A Double-blind Comparison of Buspirone and Diazepam in Outpatients with Generalized Anxiety Disorder. Ibid.Google Scholar

Copyright information

© Springer Science+Business Media New York 1985

Authors and Affiliations

  • Harold Goldberg
    • 1
  1. 1.West-Ros-Park Mental Health CenterRoslindaleUSA

Personalised recommendations